Nifty
Sensex
:
:
15746.45
52578.76
-78.00 (-0.49%)
-316.65 (-0.60%)

Pharmaceuticals & Drugs - Global

Rating :
43/99

BSE: 532531 | NSE: STAR

769.80
26-Jul-2021
  • Open
  • High
  • Low
  • Previous Close
  •  766.00
  •  789.40
  •  762.90
  •  768.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  455300
  •  3529.94
  •  999.00
  •  408.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 6,909.12
  • 25.74
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,633.76
  • 1.82%
  • 2.49

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 29.67%
  • 0.00%
  • 14.01%
  • FII
  • DII
  • Others
  • 24.82%
  • 14.83%
  • 16.67%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 0.82
  • -3.76

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 6.04
  • 16.70

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 4.87
  • -40.49

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.19
  • 23.24
  • 11.44

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.00
  • 2.25
  • 1.85

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.86
  • 13.88
  • 12.63

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Net Sales
908.49
618.64
46.85%
832.02
732.44
13.60%
793.56
715.09
10.97%
781.80
685.80
14.00%
Expenses
751.26
553.61
35.70%
672.62
551.59
21.94%
636.35
568.50
11.93%
630.79
564.88
11.67%
EBITDA
157.24
65.04
141.76%
159.41
180.84
-11.85%
157.21
146.59
7.24%
151.01
120.92
24.88%
EBIDTM
17.31%
10.51%
19.16%
24.69%
19.81%
20.50%
19.32%
17.63%
Other Income
13.05
17.65
-26.06%
14.40
13.65
5.49%
17.75
14.07
26.15%
16.20
10.25
58.05%
Interest
41.61
40.33
3.17%
34.68
39.63
-12.49%
36.87
40.42
-8.78%
36.91
35.34
4.44%
Depreciation
51.86
45.34
14.38%
52.51
43.47
20.80%
52.79
42.00
25.69%
49.13
42.89
14.55%
PBT
75.89
-173.08
-
72.85
127.02
-42.65%
98.44
161.68
-39.11%
126.08
46.29
172.37%
Tax
11.49
-10.47
-
10.77
11.30
-4.69%
6.10
7.38
-17.34%
3.28
3.12
5.13%
PAT
64.40
-162.61
-
62.07
115.72
-46.36%
92.34
154.30
-40.16%
122.80
43.17
184.46%
PATM
7.09%
-26.28%
7.46%
15.80%
11.64%
21.58%
15.71%
6.29%
EPS
5.14
-22.77
-
4.22
10.49
-59.77%
9.03
15.94
-43.35%
11.56
0.41
2,719.51%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Dec 12
Dec 11
Dec 10
Net Sales
3,315.87
2,981.12
3,108.33
3,344.37
3,826.22
2,862.19
1,195.85
1,340.96
961.76
2,550.04
1,695.84
Net Sales Growth
20.49%
-4.09%
-7.06%
-12.59%
33.68%
139.34%
-10.82%
39.43%
-62.28%
50.37%
 
Cost Of Goods Sold
1,332.79
1,122.48
1,085.20
1,378.84
1,281.17
1,502.29
560.49
714.67
491.82
1,264.39
805.65
Gross Profit
1,983.08
1,858.64
2,023.14
1,965.53
2,545.05
1,359.90
635.37
626.30
469.94
1,285.66
890.19
GP Margin
59.81%
62.35%
65.09%
58.77%
66.52%
47.51%
53.13%
46.71%
48.86%
50.42%
52.49%
Total Expenditure
2,691.02
2,470.90
2,811.65
3,108.66
3,309.30
2,481.62
967.00
1,117.54
861.18
2,059.36
1,369.22
Power & Fuel Cost
-
64.49
54.39
51.33
33.87
77.18
16.02
18.56
12.84
54.24
30.23
% Of Sales
-
2.16%
1.75%
1.53%
0.89%
2.70%
1.34%
1.38%
1.34%
2.13%
1.78%
Employee Cost
-
442.56
329.44
434.05
419.16
357.69
172.06
157.18
120.30
302.74
219.57
% Of Sales
-
14.85%
10.60%
12.98%
10.95%
12.50%
14.39%
11.72%
12.51%
11.87%
12.95%
Manufacturing Exp.
-
210.79
150.98
115.97
137.47
119.23
41.37
35.76
44.43
89.60
63.83
% Of Sales
-
7.07%
4.86%
3.47%
3.59%
4.17%
3.46%
2.67%
4.62%
3.51%
3.76%
General & Admin Exp.
-
191.89
150.10
194.38
172.63
198.71
86.25
66.37
58.16
182.12
159.16
% Of Sales
-
6.44%
4.83%
5.81%
4.51%
6.94%
7.21%
4.95%
6.05%
7.14%
9.39%
Selling & Distn. Exp.
-
137.07
111.22
208.85
161.12
129.57
61.37
66.67
39.94
116.07
88.02
% Of Sales
-
4.60%
3.58%
6.24%
4.21%
4.53%
5.13%
4.97%
4.15%
4.55%
5.19%
Miscellaneous Exp.
-
301.61
930.33
725.25
1,103.88
96.95
29.44
58.33
93.69
50.21
88.02
% Of Sales
-
10.12%
29.93%
21.69%
28.85%
3.39%
2.46%
4.35%
9.74%
1.97%
0.16%
EBITDA
624.87
510.22
296.68
235.71
516.92
380.57
228.85
223.42
100.58
490.68
326.62
EBITDA Margin
18.84%
17.12%
9.54%
7.05%
13.51%
13.30%
19.14%
16.66%
10.46%
19.24%
19.26%
Other Income
61.40
66.70
322.90
920.64
398.08
102.37
38.57
60.23
34.20
31.67
69.70
Interest
150.07
155.72
79.29
196.24
183.10
168.17
47.44
108.88
79.45
194.83
146.65
Depreciation
206.29
187.79
171.85
193.93
198.69
131.25
64.03
56.48
30.86
104.30
63.90
PBT
373.26
233.42
368.44
766.17
533.20
183.50
155.95
118.30
24.48
223.22
185.77
Tax
31.64
17.91
14.49
21.41
51.19
42.45
147.60
40.86
11.15
38.68
45.19
Tax Rate
8.48%
11.50%
3.71%
2.96%
10.30%
29.87%
99.35%
44.53%
1.54%
14.18%
24.25%
PAT
341.61
143.62
370.31
681.31
399.38
113.21
1.57
50.89
712.39
224.48
122.45
PAT before Minority Interest
352.32
137.82
375.57
701.18
445.58
99.68
0.98
50.89
713.44
234.01
141.18
Minority Interest
10.71
5.80
-5.26
-19.87
-46.20
13.53
0.59
0.00
-1.05
-9.53
-18.73
PAT Margin
10.30%
4.82%
11.91%
20.37%
10.44%
3.96%
0.13%
3.80%
74.07%
8.80%
7.22%
PAT Growth
126.86%
-61.22%
-45.65%
70.59%
252.78%
7,110.83%
-96.91%
-92.86%
217.35%
83.32%
 
EPS
38.08
16.01
41.28
75.95
44.52
12.62
0.18
5.67
79.42
25.03
13.65

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Dec 12
Dec 11
Dec 10
Shareholder's Funds
2,527.42
2,648.70
2,463.66
2,748.82
2,657.87
1,144.92
1,006.83
2,026.24
1,371.48
1,282.78
Share Capital
89.56
89.55
89.50
89.42
89.35
59.62
59.57
58.80
58.38
57.74
Total Reserves
2,432.13
2,551.59
2,365.10
2,650.55
2,562.75
1,084.50
947.06
1,963.94
1,310.34
1,222.95
Non-Current Liabilities
813.65
2,342.88
2,067.29
2,048.67
2,760.03
285.79
306.42
900.59
1,132.57
2,012.89
Secured Loans
601.79
1,806.45
1,551.09
1,622.87
2,614.88
250.23
274.29
731.15
1,054.31
1,387.39
Unsecured Loans
2.12
0.06
0.23
14.84
12.13
17.16
1.24
0.00
0.00
622.45
Long Term Provisions
63.95
52.24
16.55
25.19
14.45
6.02
16.56
57.25
66.19
0.00
Current Liabilities
2,544.86
2,662.24
1,899.30
3,103.87
1,891.98
1,019.94
707.37
1,797.29
2,791.73
923.65
Trade Payables
797.75
888.99
712.07
774.09
775.40
234.41
262.31
463.08
585.04
419.85
Other Current Liabilities
354.49
248.12
129.98
819.08
347.93
502.47
127.27
651.65
1,369.80
305.00
Short Term Borrowings
1,228.78
1,339.02
944.39
1,393.96
700.48
203.03
224.56
599.89
684.65
0.00
Short Term Provisions
163.84
186.11
112.86
116.73
68.19
80.03
93.23
82.66
152.24
198.80
Total Liabilities
5,953.17
7,806.77
6,584.90
8,034.86
7,360.09
2,469.36
2,096.29
4,795.97
5,342.24
4,491.79
Net Block
2,025.85
3,570.13
2,903.00
2,909.03
2,678.68
701.36
554.53
3,016.72
3,187.64
2,328.27
Gross Block
2,534.38
4,049.05
3,229.03
3,186.12
2,825.43
1,080.55
907.33
3,514.29
3,644.82
2,626.71
Accumulated Depreciation
508.53
478.92
326.03
277.09
146.75
379.19
352.80
497.57
457.19
298.44
Non Current Assets
3,581.05
4,758.05
4,101.31
4,243.05
3,845.20
1,039.91
787.65
3,383.87
3,711.33
2,521.48
Capital Work in Progress
412.95
453.03
620.29
780.18
814.88
171.17
99.47
241.44
285.03
191.46
Non Current Investment
503.24
494.34
350.08
315.66
127.19
68.76
41.80
0.00
0.00
1.76
Long Term Loans & Adv.
208.24
223.69
197.22
222.56
201.83
96.72
90.40
118.75
229.99
0.00
Other Non Current Assets
430.77
16.86
30.72
15.62
22.62
1.91
1.45
6.96
8.67
0.00
Current Assets
2,372.11
3,048.72
2,483.59
3,791.82
3,514.89
1,429.44
1,308.63
1,410.94
1,625.27
1,960.40
Current Investments
118.97
284.75
311.48
1,279.54
1,213.76
561.29
401.24
0.06
0.00
0.00
Inventories
782.54
874.16
552.02
732.80
613.14
207.68
175.99
442.33
479.93
312.00
Sundry Debtors
931.69
987.18
882.18
995.91
1,032.97
389.96
364.00
483.23
538.44
383.78
Cash & Bank
237.10
516.65
303.33
329.48
311.59
146.88
231.15
165.74
259.73
339.45
Other Current Assets
301.81
136.87
138.84
209.70
343.44
123.64
136.26
319.58
347.17
925.17
Short Term Loans & Adv.
218.24
249.11
295.75
244.39
97.54
54.46
79.06
44.38
91.79
850.18
Net Current Assets
-172.75
386.48
584.29
687.95
1,622.91
409.50
601.26
-386.35
-1,166.46
1,036.75
Total Assets
5,953.16
7,806.77
6,584.90
8,034.87
7,360.09
2,469.35
2,096.28
4,795.98
5,342.23
4,491.80

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Dec 12
Dec 11
Dec 10
Cash From Operating Activity
204.79
60.05
187.07
288.14
73.25
83.40
-271.68
134.26
457.10
323.93
PBT
48.51
344.37
705.80
497.14
146.44
992.01
2,889.87
949.49
272.69
186.37
Adjustment
527.49
94.59
-274.51
190.92
345.56
-756.73
-2,775.01
-415.93
113.84
178.94
Changes in Working Capital
-326.23
-323.14
-190.66
-341.30
-341.71
-95.91
-260.68
-310.56
128.87
-2.09
Cash after chg. in Working capital
249.76
115.82
240.63
346.76
150.29
139.37
-145.81
223.00
515.40
363.23
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-44.98
-55.76
-53.56
-58.62
-77.04
-55.97
-125.87
-88.75
-58.30
-39.29
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
1,306.16
-148.49
582.59
-686.69
-2,224.83
51.87
4,077.09
806.54
-656.47
-941.00
Net Fixed Assets
-115.07
-48.49
677.20
-236.66
-535.93
-66.57
-119.10
-38.27
-18.46
-42.91
Net Investments
-17.17
-383.09
747.64
-143.27
-1,478.58
78.09
248.81
-508.54
77.70
653.52
Others
1,438.40
283.09
-842.25
-306.76
-210.32
40.35
3,947.38
1,353.35
-715.71
-1,551.61
Cash from Financing Activity
-1,709.45
194.27
-1,015.69
338.21
2,943.94
-421.25
-3,318.53
-990.03
89.36
850.09
Net Cash Inflow / Outflow
-198.50
105.83
-246.03
-60.33
792.35
-285.98
486.88
-49.23
-110.01
233.03
Opening Cash & Equivalents
365.89
256.16
515.08
1,110.74
298.91
586.00
132.02
211.93
325.17
79.00
Closing Cash & Equivalent
182.23
365.89
256.16
515.08
1,110.74
298.42
586.00
132.02
212.27
325.17

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Dec 12
Dec 11
Dec 10
Book Value (Rs.)
281.55
294.94
274.26
306.41
296.83
191.91
168.99
343.78
233.49
220.07
ROA
2.00%
5.22%
9.59%
5.79%
2.03%
0.04%
1.48%
14.07%
4.76%
3.66%
ROE
5.34%
14.74%
27.00%
16.53%
5.25%
0.09%
3.36%
42.16%
17.77%
13.87%
ROCE
6.01%
8.65%
16.07%
10.75%
7.54%
10.92%
7.76%
21.08%
12.82%
11.96%
Fixed Asset Turnover
1.50
1.17
1.04
1.27
1.47
1.21
0.61
0.27
0.82
0.72
Receivable days
70.88
79.95
102.49
96.77
90.73
114.71
114.80
193.43
65.68
86.42
Inventory Days
61.20
61.00
70.11
64.20
52.34
58.37
83.78
174.61
56.40
58.62
Payable days
138.58
146.59
116.23
117.33
75.51
76.81
112.69
253.28
92.58
119.83
Cash Conversion Cycle
-6.50
-5.64
56.37
43.64
67.55
96.27
85.89
114.76
29.50
25.22
Total Debt/Equity
0.78
1.22
1.03
1.35
1.34
0.78
0.54
0.79
1.94
1.58
Interest Cover
2.00
5.92
4.68
3.71
1.85
4.13
1.84
10.12
2.40
2.27

News Update:


  • Strides Pharma Science’s Puducherry facility successfully completes EU GMP inspection
    28th Jun 2021, 16:57 PM

    The inspection was carried out on April 28, 2021 and the company has now received the renewed GMP certificate

    Read More
  • Strides Pharma Science’s arm inks pact with Ennaid Therapeutics
    15th Jun 2021, 09:09 AM

    Partnership aims to produce an oral medication to treat patients with mild and asymptomatic COVID-19

    Read More
  • Strides Pharma Science, TLC partner to launch Liposomal Amphotericin B
    27th May 2021, 15:27 PM

    Liposomal Amphotericin B, a drug used in the treatment of mucormycosis (black fungus)

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.